AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$463,000+10.2% YoY

Gross Profit

-$41M-8837.8% margin

Operating Income

-$56M-12129.2% margin

Net Income

-$64M-13848.8% margin

EPS (Diluted)

$-0.76

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$146M

Total Liabilities

$33M

Stockholders' Equity

$113M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$463,000	$420,000	+10.2%
Gross Profit	-$41M	$419,000	-9865.9%
Operating Income	-$56M	-$47M	-19.3%
Net Income	-$64M	-$71M	+9.4%

AUPH FY 2018 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena